SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-322041
Filing Date
2018-11-08
Accepted
2018-11-08 09:10:58
Documents
3
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d647782d8k.htm 8-K 15685
2 EX-99.1 d647782dex991.htm EX-99.1 45028
3 GRAPHIC g647782g1107184321775.jpg GRAPHIC 3637
  Complete submission text file 0001193125-18-322041.txt   67129
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 181168418
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1